Curculigoside Protects against Excess-Iron-Induced Bone Loss by Attenuating Akt-FoxO1-Dependent Oxidative Damage to Mice and Osteoblastic MC3T3-E1 Cells
Open Access
- 19 December 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-14
Abstract
Summary. The present investigation found that curculigoside (CUR) can prevent excess-iron-induced bone loss in mice and cells through antioxidation and inhibiting excess-iron-induced phosphorylation of the Akt-FoxO1 pathway. CUR can attenuate the decreasing of cell viability, enhance autophagy, potentiate the antioxidant effect, and reduce apoptosis in MC3T3-E1 cells treated with excess iron through regulating the expression of FoxO1 target gene. Introduction. Oxidative stress induced by iron overload is an important factor involved in primary osteoporosis disease and iron overload-related diseases. Curculigoside (CUR), a phenolic glycoside found abundantly in Curculigo orchioides Gaertn., has been demonstrated to possess antioxidant and antiosteoporotic properties. The aim of the present study is to explore the underlying molecular mechanism of CUR on excess-iron-induced bone loss in mice and osteoblastic MC3T3-E1 cells. Methods. An iron-overload mice model was used to study the protective effects of CUR on bone loss induced by oxidative stress. Serum bone metabolism markers and antioxidant enzymes were also measured. To explore the antioxidant mechanism of CUR, the MC3T3-E1 osteoblastic cell line was used. Results. In vivo studies showed that BMD and microarchitectural parameters were improved after a 3-month administration of CUR. CUR improved the biochemical parameters related to bone metabolism and the expressions of Runx2, OCN, and type 1 collagen and increased the formation of bone-mineralized nodules in vitro. CUR also inhibited ROS generation and increased the activities of antioxidant enzymes both in vivo and in vitro treated with excess iron. CUR can upregulate the level of FoxO1 and Nrf2, downregulate the level of p53 and the phosphorylation level of FoxO1, improve nuclear translocation of FoxO1, probably by inhibiting the IGFR/AKT signaling pathway, then increased cell viability and autophagy, and reduced apoptosis of MC3T3-E1 cells treated with excess iron by regulating the expression of FoxO1 target genes MnSOD, Gadd45a, Bim, FasL, and Rab7. Conclusions. These results demonstrated that CUR was able to alleviate bone loss induced by oxidative stress resulting from iron overload, suggesting its potential use for the treatment of primary osteoporosis and bone loss in iron-overload-related diseases.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20170265, KC17103, LY19H280002, 81973534)
- Xuzhou Science and Technology Project (BK20170265, KC17103, LY19H280002, 81973534)
- Natural Science Foundation of Zhejiang Province (BK20170265, KC17103, LY19H280002, 81973534)
- National Natural Science Foundation of China (BK20170265, KC17103, LY19H280002, 81973534)
This publication has 33 references indexed in Scilit:
- Ameliorative Effects of Curculigoside from Curculigo orchioides Gaertn on Learning and Memory in Aged RatsMolecules, 2012
- Study on the Effects of Curculigoside on Proliferation, Differentiation, and Calcification of Mouse Osteoblastic MC3T3-E1 CellsWorld Science and Technology, 2011
- Up‐regulation of VEGF by MC3T3‐E1 Cells Treated with CurculigosidePhytotherapy Research, 2011
- p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathwayAmerican Journal of Physiology-Renal Physiology, 2010
- Bone loss caused by iron overload in a murine model: importance of oxidative stressBlood, 2010
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- FoxO1 Is a Positive Regulator of Bone Formation by Favoring Protein Synthesis and Resistance to Oxidative Stress in OsteoblastsCell Metabolism, 2010
- Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting β-Catenin from T Cell Factor- to Forkhead Box O-mediated TranscriptionJournal of Biological Chemistry, 2007
- p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodelingJournal of Cell Biology, 2005
- Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κBBiochemical and Biophysical Research Communications, 2004